Clinical Trial Update: Angiotensinogen Variants and Adverse Pregnancy Outcomes

View source ↗

Summary

A completed University of Utah study investigates whether angiotensinogen variants influence adverse pregnancy outcomes, including pre-eclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Pre-eclampsia

Snippet

Sponsor: University of Utah | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED